Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...

Oral Factor Xa inhibitors, such as apixaban and rivaroxaban, have revolutionized anticoagulation therapy, providing effective stroke prevention and ...

From his lab at the University of Houston College of Pharmacy Drug Discovery Institute ... Lianjie Miao, research assistant professor of pharmacology, is the paper’s first author. The signals are ...

We aim at discovering new ways to treat heart diseases by investigating the molecular mechanisms of genetic cardiac diseases as well as cardiac regeneration and remodelling, and thereby identifying ...

cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and ...

obesity and cardiovascular disease. Aguilar, R. Claudio claudio@purdue.edu Biological Sciences Target Discovery & Characterization Cancer, Neurological Disorder/Trauma Altman, Ryan raaltman@purdue.edu ...

Our faculty pursue a variety of scientific interests in the areas of neurological disorders, cancer therapeutics, pain, cardiovascular ... graduate programs in Pharmacology and Physiology (MS and PhD) ...